Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers
Clinical trial NCT02381470 · COMPLETED
Trial details
- NCT number
- NCT02381470
- Sponsor
- National University Hospital, Singapore
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-11
- Primary completion
- 2019-09-28
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.